US Stock MarketDetailed Quotes

LVTX LAVA Therapeutics

Watchlist

2.290
+0.010+0.44%

Close Jun 7 16:00 ET

60.21MMarket Cap-2160P/E (TTM)

LAVA Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

471.24%6.99M

-65.09%6.77M

-86.63%353K

-99.65%53K

998.08%5.14M

19.77%1.22M

262.45%19.39M

147.65%2.64M

628.45%15.26M

-56.67%468K

Operating revenue

471.24%6.99M

-65.09%6.77M

-86.63%353K

-99.65%53K

998.08%5.14M

19.77%1.22M

262.45%19.39M

147.65%2.64M

628.45%15.26M

-56.67%468K

Cost of revenue

3.48M

154K

10K

2.39M

930K

Gross profit

2,278.23%6.99M

-83.05%3.29M

-92.46%199K

-99.72%43K

487.82%2.75M

-71.23%294K

262.45%19.39M

2.64M

15.26M

468K

Operating expense

-35.34%8.94M

-14.18%46.54M

-60.05%5.64M

-36.01%10.77M

41.16%16.3M

17.89%13.83M

10.76%54.23M

35.73%14.12M

60.87%16.83M

50.72%11.54M

Selling and administrative expenses

-24.55%2.94M

-9.90%12.73M

-36.27%2.28M

-8.84%2.86M

16.51%3.7M

-8.19%3.89M

17.52%14.12M

-5.02%3.58M

-16.62%3.14M

14.80%3.17M

-General and administrative expense

-24.55%2.94M

-9.90%12.73M

-36.27%2.28M

-8.84%2.86M

16.51%3.7M

-8.19%3.89M

17.52%14.12M

-5.02%3.58M

-16.62%3.14M

14.80%3.17M

Research and development costs

-39.57%6.01M

-15.69%33.81M

-68.12%3.36M

-42.24%7.91M

50.51%12.6M

32.63%9.94M

8.55%40.11M

58.88%10.54M

104.34%13.7M

71.01%8.37M

Operating profit

85.58%-1.95M

-24.15%-43.25M

52.59%-5.44M

-582.81%-10.73M

-22.29%-13.55M

-26.39%-13.54M

20.12%-34.84M

-22.95%-11.48M

81.23%-1.57M

-68.35%-11.08M

Net non-operating interest income expense

31.28%810K

1,055.64%2.97M

79.62%846K

1,974.36%809K

875.56%698K

478.53%617K

141.12%257K

411.92%471K

124.68%39K

51.87%-90K

Non-operating interest income

31.28%810K

844.54%3.2M

----

--617K

--339K

----

Non-operating interest expense

----

182.93%232K

----

-86.88%82K

----

Total other finance cost

----

-1,974.36%-809K

-875.56%-698K

----

-124.68%-39K

--90K

Other net income (expense)

169.48%658K

-148.31%-1.41M

52.06%-1.84M

-54.99%1.13M

-92.22%244K

-185.16%-947K

43.28%2.92M

-389.81%-3.84M

53.63%2.52M

353.11%3.14M

Gain on sale of security

169.48%658K

-148.31%-1.41M

52.06%-1.84M

-54.99%1.13M

-92.22%244K

-185.16%-947K

43.28%2.92M

-389.81%-3.84M

53.63%2.52M

353.11%3.14M

Income before tax

96.51%-484K

-31.70%-41.7M

56.65%-6.44M

-993.79%-8.79M

-56.95%-12.6M

-42.06%-13.87M

24.98%-31.66M

-81.92%-14.85M

114.27%983K

-0.31%-8.03M

Income tax

-2.82%69K

12.05%279K

-8.96%61K

6.38%50K

27.63%97K

20.34%71K

58.60%249K

17.54%67K

6.82%47K

137.50%76K

Net income

96.03%-553K

-31.55%-41.97M

56.43%-6.5M

-1,044.02%-8.84M

-56.67%-12.7M

-41.93%-13.94M

24.67%-31.91M

-81.47%-14.92M

113.50%936K

-0.86%-8.11M

Net income continuous Operations

96.03%-553K

-31.55%-41.97M

56.43%-6.5M

-1,044.02%-8.84M

-56.67%-12.7M

-41.93%-13.94M

24.67%-31.91M

-81.47%-14.92M

113.50%936K

-0.86%-8.11M

Minority interest income

Net income attributable to the parent company

96.03%-553K

-31.55%-41.97M

56.43%-6.5M

-1,044.02%-8.84M

-56.67%-12.7M

-41.93%-13.94M

24.67%-31.91M

-81.47%-14.92M

113.50%936K

-0.86%-8.11M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

96.03%-553K

-31.55%-41.97M

56.43%-6.5M

-1,044.02%-8.84M

-56.67%-12.7M

-41.93%-13.94M

24.67%-31.91M

-81.47%-14.92M

113.50%936K

-0.86%-8.11M

Basic earnings per share

96.23%-0.02

-27.64%-1.57

61.40%-0.22

-950.00%-0.34

-54.84%-0.48

-39.47%-0.53

42.52%-1.23

-50.00%-0.57

114.81%0.04

0.00%-0.31

Diluted earnings per share

96.23%-0.02

-27.64%-1.57

61.40%-0.22

-950.00%-0.34

-54.84%-0.48

-39.47%-0.53

42.52%-1.23

-50.00%-0.57

114.81%0.04

0.00%-0.31

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	471.24%6.99M	-65.09%6.77M	-86.63%353K	-99.65%53K	998.08%5.14M	19.77%1.22M	262.45%19.39M	147.65%2.64M	628.45%15.26M	-56.67%468K
Operating revenue	471.24%6.99M	-65.09%6.77M	-86.63%353K	-99.65%53K	998.08%5.14M	19.77%1.22M	262.45%19.39M	147.65%2.64M	628.45%15.26M	-56.67%468K
Cost of revenue	0	3.48M	154K	10K	2.39M	930K	0	0	0	0
Gross profit	2,278.23%6.99M	-83.05%3.29M	-92.46%199K	-99.72%43K	487.82%2.75M	-71.23%294K	262.45%19.39M	2.64M	15.26M	468K
Operating expense	-35.34%8.94M	-14.18%46.54M	-60.05%5.64M	-36.01%10.77M	41.16%16.3M	17.89%13.83M	10.76%54.23M	35.73%14.12M	60.87%16.83M	50.72%11.54M
Selling and administrative expenses	-24.55%2.94M	-9.90%12.73M	-36.27%2.28M	-8.84%2.86M	16.51%3.7M	-8.19%3.89M	17.52%14.12M	-5.02%3.58M	-16.62%3.14M	14.80%3.17M
-General and administrative expense	-24.55%2.94M	-9.90%12.73M	-36.27%2.28M	-8.84%2.86M	16.51%3.7M	-8.19%3.89M	17.52%14.12M	-5.02%3.58M	-16.62%3.14M	14.80%3.17M
Research and development costs	-39.57%6.01M	-15.69%33.81M	-68.12%3.36M	-42.24%7.91M	50.51%12.6M	32.63%9.94M	8.55%40.11M	58.88%10.54M	104.34%13.7M	71.01%8.37M
Operating profit	85.58%-1.95M	-24.15%-43.25M	52.59%-5.44M	-582.81%-10.73M	-22.29%-13.55M	-26.39%-13.54M	20.12%-34.84M	-22.95%-11.48M	81.23%-1.57M	-68.35%-11.08M
Net non-operating interest income expense	31.28%810K	1,055.64%2.97M	79.62%846K	1,974.36%809K	875.56%698K	478.53%617K	141.12%257K	411.92%471K	124.68%39K	51.87%-90K
Non-operating interest income	31.28%810K	844.54%3.2M	----	----	----	--617K	--339K	----	----	----
Non-operating interest expense	----	182.93%232K	----	----	----	----	-86.88%82K	----	----	----
Total other finance cost	----	----	----	-1,974.36%-809K	-875.56%-698K	----	----	----	-124.68%-39K	--90K
Other net income (expense)	169.48%658K	-148.31%-1.41M	52.06%-1.84M	-54.99%1.13M	-92.22%244K	-185.16%-947K	43.28%2.92M	-389.81%-3.84M	53.63%2.52M	353.11%3.14M
Gain on sale of security	169.48%658K	-148.31%-1.41M	52.06%-1.84M	-54.99%1.13M	-92.22%244K	-185.16%-947K	43.28%2.92M	-389.81%-3.84M	53.63%2.52M	353.11%3.14M
Income before tax	96.51%-484K	-31.70%-41.7M	56.65%-6.44M	-993.79%-8.79M	-56.95%-12.6M	-42.06%-13.87M	24.98%-31.66M	-81.92%-14.85M	114.27%983K	-0.31%-8.03M
Income tax	-2.82%69K	12.05%279K	-8.96%61K	6.38%50K	27.63%97K	20.34%71K	58.60%249K	17.54%67K	6.82%47K	137.50%76K
Net income	96.03%-553K	-31.55%-41.97M	56.43%-6.5M	-1,044.02%-8.84M	-56.67%-12.7M	-41.93%-13.94M	24.67%-31.91M	-81.47%-14.92M	113.50%936K	-0.86%-8.11M
Net income continuous Operations	96.03%-553K	-31.55%-41.97M	56.43%-6.5M	-1,044.02%-8.84M	-56.67%-12.7M	-41.93%-13.94M	24.67%-31.91M	-81.47%-14.92M	113.50%936K	-0.86%-8.11M
Minority interest income
Net income attributable to the parent company	96.03%-553K	-31.55%-41.97M	56.43%-6.5M	-1,044.02%-8.84M	-56.67%-12.7M	-41.93%-13.94M	24.67%-31.91M	-81.47%-14.92M	113.50%936K	-0.86%-8.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	96.03%-553K	-31.55%-41.97M	56.43%-6.5M	-1,044.02%-8.84M	-56.67%-12.7M	-41.93%-13.94M	24.67%-31.91M	-81.47%-14.92M	113.50%936K	-0.86%-8.11M
Basic earnings per share	96.23%-0.02	-27.64%-1.57	61.40%-0.22	-950.00%-0.34	-54.84%-0.48	-39.47%-0.53	42.52%-1.23	-50.00%-0.57	114.81%0.04	0.00%-0.31
Diluted earnings per share	96.23%-0.02	-27.64%-1.57	61.40%-0.22	-950.00%-0.34	-54.84%-0.48	-39.47%-0.53	42.52%-1.23	-50.00%-0.57	114.81%0.04	0.00%-0.31
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall